Business
Only 40% of Australians want the AstraZeneca vaccine. What could this mean for CSL (ASX:CSL)?
New data reveals that only 40% of Australians are willing to take the AstraZeneca plc (LSE: AZN) COVID-19 vaccine. What, if anything, could this mean for CSL Limited (ASX: CSL)?. The data, released Monday in an Essential Research poll, comes at an inopportune time for the country as a whole, with the inoculation roll-out already delayed.
With CSL being the main manufacturer and distributor of the AstraZeneca vaccine in Australia, it would be interesting to know what the company makes of the latest figures.
Let’s take a closer look at the data.
1 in 5 Australian women refuse to get vaccinated
Since…
-
Noosa News23 hours agoNRL finals live updates: Melbourne Storm vs Canterbury Bulldogs — blog, scores and stats
-
Noosa News24 hours agoStolen hearse crashes into two cars in peak-hour collision at Parkwood on the Gold Coast
-
General21 hours agoPrince Harry arrives in Kyiv to meet with wounded Ukrainian war veterans
-
Noosa News23 hours agoApartment block proposed for Racecourse Road shopping strip